House lawmaker raises new concerns over FDA’s ultra-fast drug review program
By MATTHEW PERRONE WASHINGTON (AP) — A Democratic lawmaker raised new concerns about a Food and Drug Administration program designed to drastically shorten the review of certain drugs, including whether senior officials involved in the effort are complying with federal … Continued